682P Results from ADVANCE: A phase I/II open-label non-randomised safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 (VTP-800) vaccine in combination with PD-1 checkpoint blockade in metastatic prostate cancer
| Autor: | Tuthill, M., Cappuccini, F., Carter, L., Pollock, E., Poulton, I., Verrill, C., Evans, T., Gillessen, S., Attard, G., Protheroe, A., Hamdy, F., Hill, A.V.S., Redchenko, I. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S543-S543 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|